Advanced search    

Search: authors:"G. Heinrich"

16 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Higgs boson pair production at NNLO with top quark mass effects

2016 , CMS- PAS-FTR- 16- 002 [INSPIRE]. [3] J. Baglio , A. Djouadi , R. Grober, M.M. Muhlleitner, J. Quevillon and M. Spira , The [19] G. Heinrich , S.P. Jones , M. Kerner , G. Luisoni and E. Vryonidou ... Model and beyond , Eur. Phys. J. C 74 ( 2014 ) 3001 [arXiv: 1404 .7096] [INSPIRE]. [41] S.P. Jones , Automation of 2-loop Amplitude Calculations, PoS(LL2016) 069 [43] S. Borowka , G. Heinrich, S.P. Jones

NLO predictions for Higgs boson pair production with full top quark mass dependence matched to parton showers

at NLO with GoSam, Acta Phys. Polon. B 44 (2013) 2223 [INSPIRE]. [82] T. Binoth, J.P. Guillet, G. Heinrich, E. Pilon and T. Reiter, Golem95: a numerical program to calculate one-loop tensor integrals ... . Commun. 182 (2011) 2276 [arXiv:1101.5595] [INSPIRE]. [84] J.P. Guillet, G. Heinrich and J.F. von Soden-Fraunhofen, Tools for NLO automation: extension of the golem95C integral library, Comput. Phys. Commun

Full top quark mass dependence in Higgs boson pair production at NLO

. Henn, F. Moriello and V.A. Smirnov, [85] J. Carter and G. Heinrich, SecDec: a general program for sector decomposition, Comput. [86] S. Borowka, J. Carter and G. Heinrich, Numerical evaluation of multi ... -loop integrals for [87] S. Borowka, G. Heinrich, S.P. Jones, M. Kerner, J. Schlenk and T. Zirke, SecDec-3.0: [88] A. von Manteu el, E. Panzer and R.M. Schabinger, A quasi- nite basis for multi-loop [89

Renormalization scheme dependence of the two-loop QCD corrections to the neutral Higgs-boson masses in the MSSM

. Heinemeyer , G. Heinrich , W. Hollik , Eur. Phys. J. C 74 ( 8 ), 2994 ( 2014 ). arXiv: 1404 .7074 [hep-ph] 2. G. Degrassi , S. Di Vita , P. Slavich , Eur. Phys. J. C 75 ( 2 ), 61 ( 2015 ). arXiv: 1410 .3432 ... al., Eur. Phys. J. C 74 , 3 ( 2014 ). arXiv: 1312 .5233 [hep-ph] 64. J. Carter , G. Heinrich , Comput. Phys. Commun . 182 , 1566 ( 2011 ). arXiv: 1011 .5493 [hep-ph] 65. S. Borowka , J. Carter , G

The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial

Background HER2 is one of the predominant therapeutic targets in breast cancer. The metastatic selection process may lead to discrepancies between the HER2 status of the primary tumor and circulating tumor cells (CTCs). This study analyzed the HER2 status of CTCs in patients with HER2-positive primary breast cancer at the time of diagnosis. Aim of the study was to assess...

Anomalous coupling, top-mass and parton-shower effects in W + W − production

and squared quark-loop corrections to four-lepton +0; 1 jet production, JHEP 01 (2014) 046 [arXiv:1309.0500] [INSPIRE]. [56] G. Cullen, N. Greiner, G. Heinrich, G. Luisoni, P. Mastrolia, G. Ossola et al ... ] [INSPIRE]. [72] T. Binoth, J.P. Guillet, G. Heinrich, E. Pilon and T. Reiter, Golem95: A Numerical program to calculate one-loop tensor integrals with up to six external legs, Comput. Phys. Commun. 180 (2009

Momentum-dependent two-loop QCD corrections to the neutral Higgs-boson masses in the MSSM

Results are presented for the momentum-dependent two-loop contributions of \(\mathcal{O}(\alpha _t\alpha _s)\) to the masses and mixing effects in the Higgs sector of the MSSM. They are obtained in the Feynman-diagrammatic approach using a mixed on-shell/ \(\overline{{\mathrm {DR}}}\) renormalization that can directly be matched onto the higher-order corrections included in the...

Tensorial reconstruction at the integrand level

We present a new approach to the reduction of one-loop amplitudes obtained by reconstructing the tensorial expression of the scattering amplitudes. The reconstruction is performed at the integrand level by means of a sampling in the integration momentum. There are several interesting applications of this novel method within existing techniques for the reduction of one-loop multi...

A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study

J. Sehouli 9 I. B. Runnebaum 8 C. Fotopoulou 9 U. Blohmer 7 A. Belau 14 H. Leber 13 L. C. Hanker 12 W. Hartmann 11 R. Richter 9 M. D. Keyver-Paik 16 C. Oberhoff 15 G. Heinrich 10 A. du Bois 5 C

Increased metabolic rate and insulin sensitivity in male mice lacking the carcino-embryonic antigen-related cell adhesion molecule 2

Aims/hypothesis The carcino-embryonic antigen-related cell adhesion molecule (CEACAM)2 is produced in many feeding control centres in the brain, but not in peripheral insulin-targeted tissues. Global Ceacam2 null mutation causes insulin resistance and obesity resulting from hyperphagia and hypometabolism in female Ceacam2 homozygous null mutant mice (Cc2 [also known as Ceacam2...

The fates of the blastomeres of the 16-cell zebrafish embryo

Street, Boston, MA 02118 , USA 1 Harvard University , Biological Laboratories, 16 Divinity Avenue, Cambridge, MA 02138 , USA 2 D. Strehlow , G. Heinrich and W. Gilbert *Author for correspondence SUMMARY

Biweekly pegylated liposomal doxorubicin in patients with relapsed ovarian cancer: results of a multicenter phase-II trial

Background: The obvious benefit of pegylated liposomal doxorubicin (PLD) for tumour control in recurrent ovarian cancer is frequently offset by severe palmar-plantar erythrodysesthesia (PPE). There is evidence that dose reduction from 50 to 40 mg/m2 reduces the incidence of PPE without compromising cytotoxic activity. We set out to investigate whether biweekly application further...

In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study

G. von Minckwitz 3 J.-U. Blohmer 1 G. Raab 0 A. L ohr 7 B. Gerber 6 G. Heinrich 5 H. Eidtmann 4 M. Kaufmann 9 J. Hilfrich 8 C. Jackisch 2 I. Zuna 10 S. D. Costa 11 On behalf of the German Breast

A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy

Background: Second-line chemotherapy for patients with ovarian cancer who failed platinum and paclitaxel treatment remains a therapeutic challenge. We investigated the toxicity profile and therapeutic efficacy of a novel combination regimen, topotecan plus gemcitabine, in a clinical phase II study. Patients and methods: Women with relapsed epithelial ovarian cancer after platinum...